| 摘要 |
A food additive or pharmaceutical composition comprises a chitin derivative having a free amino group, preferably chitosan, ascorbic acid and a swelling agent. The composition may be presented in a gelatine capsule. The swelling agent, preferably an organic acid such as citric or lactic acid, enhances the lipid binding capacity of the chitosan matrix in the gut. |
